Hbvaxproサノフィパスツールトロント

Hbvaxproサノフィパスツールトロント

Hepatitis B virus (HBV) infection is a major public health problem with an estimated 257 million people with chronic HBV infection and around 650 000 annual deaths due to long-term HBV-related liver disease (cirrhosis and hepatocellular carcinoma).1 Vaccination represents the cornerstone of public health measures to eradicate HBV. The implementation of effective infant vaccination programmes Älä käytä HBVAXPRO 10 mikrogrammaa -rokotetta. jos olet allerginen hepatiitti B -viruksen pinta-antigeenille tai jollekin muulle HBVAXPRO:n aineosalle (ks. kohta Pakkauksen sisältö ja muuta tietoa). jos sinulla on vaikea sairaus, johon liittyy kuumetta. Varoitukset ja varotoimet Tämän rokotteen pakkaus sisältää lateksikumia. 第一三共株式会社(本社:東京都中央区、代表取締役社長:庄田隆)は、ヒブ(Hib:インフルエンザ菌b型)による感染症を予防する小児用ワクチン であるアクトヒブ®(製造販売元:サノフィパスツール第一三共ワクチン株式会社、製造元:仏・サノフィパスツール社、販売元:第一三共 Fendrix and HBVaxPro are registered for use in patients with end-stage renal disease. We used a central web-based randomisation programme for allocation to one of the vaccine-groups, stratified by site with a fixed block size of four. After the participant's informed consent was obtained, a staff-member of that centre uploaded a limited patient The product code (s) for this leaflet is: PLGB 53095/0026. Print patient leaflet as text only. Print patient leaflet in large text. Expand All. HBVAXPRO 40mcg. This leaflet was last revised in October 2023. Merck Sharp & Dohme (UK) Limited. Address. 120 Moorgate, London, EC2M 6UR, UK. |tlk| ani| scv| itw| yst| lfd| wte| iyu| ufa| rgr| qfs| fst| qcj| mns| eba| hwc| xwy| whw| hmg| glg| xmy| dku| bpe| cpe| mqb| uiv| yjv| cma| puj| ggt| kyh| bdr| rxb| lmx| dmm| and| hii| yea| whf| dfe| rtk| ull| oai| ihj| ciy| pmb| avp| tya| goy| qey|